Testosterone slows prostate cancer recurrence in low-risk patients

In the largest such study so far undertaken, US researchers have shown that testosterone replacement slows the recurrence of prostate cancer in low-risk patients. This may call into question the general applicability of Nobel-Prize winning hormonal prostate treatment. The work is presented at the European Association of Urology congress in Barcelona. Background Doctors have long…

Details

Key to successful care of pregnant women in heart failure? Team-based care, study finds

IMAGE: In case study presented at the American College of Cardiology Scientific Sessions in New Orleans, clinicians from the Intermountain Healthcare Heart Institute demonstrated how multiple medical teams across several different… view more  Any time a pregnant woman presents in heart failure there are risks to both mother and baby. What does it take to protect…

Details

In study, TAVR is superior to surgery for low-risk patients with aortic valve stenosis

A multicenter clinical trial has found that transcatheter aortic valve replacement (TAVR) performed better than open-heart surgery in low-risk patients with severe aortic stenosis. The study found that one year after the procedure, the rate of death, stroke, or rehospitalization was significantly lower with TAVR than with surgery. The results were presented during the late-breaking…

Details